SCHEMBL17690368

SCHEMBL17690368

c1ccc(-n2c3ccccc3c3cc(-c4ccc(-c5cccc6cccc(-c7ccc(-c8cccnc8)cc7)c56)cc4)ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.42
CYP19A1 P11511 2/20 0.42
CYP11B2 P19099 2/20 0.42
CYP17A1 P05093 1/20 0.42
MAPT P10636 4/20 0.40
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TNF P01375 1/20 0.39
PIK3CA P42336 1/20 0.38
DHODH Q02127 1/20 0.38
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MKNK1 Q9BUB5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17690374 0.91 CYP11B1 (0.43) CYP11B1CYP19A1CYP11B2CYP17A1MAPT
SCHEMBL17690369 0.89 KDM4E (0.43) MAPTMAPK1HSD17B10KDM4EATM
SCHEMBL25972734 0.89 L3MBTL1 (0.50) MAPTMAPK1HTTHSD17B10KDM4E
SCHEMBL19041643 0.88 KDM4E (0.40) CYP11B1CYP11B2MAPTMAPK1KDM4E
SCHEMBL25972768 0.87 L3MBTL1 (0.49) MAPTMAPK1HTTHSD17B10KDM4E
SCHEMBL18790308 0.87 KDM4E (0.49) CYP11B1CYP19A1CYP11B2CYP17A1MAPT
SCHEMBL19762218 0.87 KDM4E (0.49) CYP11B1CYP19A1CYP11B2CYP17A1MAPT
SCHEMBL23057379 0.87 L3MBTL1 (0.51) CYP11B1CYP19A1CYP11B2CYP17A1MAPT
SCHEMBL26767605 0.87 CYP11B1 (0.38) CYP11B1CYP19A1CYP11B2CYP17A1MAPT
SCHEMBL19763282 0.86 KDM4E (0.45) CYP11B1CYP19A1CYP11B2CYP17A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10892419-B2 Space-through charge transfer compound, and organic light emitting diode and display device using the same LG DISPLAY CO., LTD. (KR) 2021-01-12 US disclosed
US-20190081244-A1 Space-Through Charge Transfer Compound, and Organic Light Emitting Diode and Display Device Using the Same LG DISPLAY CO., LTD. (KR) 2019-03-14 US disclosed
EP-3010064-B1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO LTD (KR) 2017-07-19 EP disclosed
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2016-04-21 US disclosed
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2016-04-21 US disclosed
EP-3010064-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME LG Display Co., Ltd. (KR) 2016-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10892419-B2 Space-through charge transfer compound, and organic light emitting diode and display device using the same NLRP1, NLRP3, CYBA CYP11B1 814/4885CYP19A1 1469/4885CYP11B2 827/4885
US-20160111650-A1 SPACE-THROUGH CHARGE TRANSFER COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME NLRP1, NLRP3, CYBA CYP11B1 814/4885CYP19A1 1469/4885CYP11B2 827/4885
US-20190081244-A1 Space-Through Charge Transfer Compound, and Organic Light Emitting Diode and Display Device Using the Same NLRP1, NLRP3, CYBA CYP11B1 814/4885CYP19A1 1469/4885CYP11B2 827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.